HG6-64-1 (Synonyms: HMSL 10017-101-1) |
| Catalog No.GC36223 |
HG6-64-1은 특허 WO 2011090738 A2, 실시예 9(XI-1)에서 추출된 강력하고 선택적인 B-Raf 억제제이고; B-raf V600E 형질전환된 Ba/F3 세포에서 IC50이 0.09μM입니다.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1315329-43-1
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
HG6-64-1 is a potent and selective B-Raf inhibitor extracted from patent WO 2011090738 A2, example 9 (XI-1); has a IC50 of 0.09 μM on B-raf V600E transformed Ba/F3 cells. B-RafV600E|0.09 μM (IC50, in Ba/F3 cells)
[1]. WO 2011090738 A2
Review for HG6-64-1
Average Rating: 5 (Based on Reviews and 8 reference(s) in Google Scholar.)
Review for HG6-64-1
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *